Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
March 25, 2026
Ten-Year Trends in Healthcare Use and Costs for People Living with Diabetes in France: Results from the Epicodiab Study Based on National Claims Data
Michael Joubert, Pierre Serusclat, Emilie Casarotto, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
September 3, 2025
Nationwide Trends in Type 1 and Type 2 Diabetes in France (2010-2019): A Population-Based Study Using a Machine Learning Classification Algorithm
Guy Fagherazzi, Pierre Serusclat, Barbara Roux, et al.
Diabetes Care
|
August 17, 2016
Benefits of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide, Versus Insulin Glargine and Lixisenatide Monocomponents in Type 2 Diabetes Inadequately Controlled on Oral Agents: The LixiLan-O Randomized Trial
Julio Rosenstock, Ronnie Aronson, George Grunberger, et al.
JAMA
|
March 24, 2019
Effect of Additional Oral Semaglutide vs Sitagliptin on Glycated Hemoglobin in Adults With Type 2 Diabetes Uncontrolled With Metformin Alone or With Sulfonylurea: The PIONEER 3 Randomized Clinical Trial
Julio Rosenstock, Dale Allison, Andreas L Birkenfeld, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
May 19, 2019
Safety and Effectiveness of Bexagliflozin in Patients With Type 2 Diabetes Mellitus and Stage 3a/3b CKD
Andrew S Allegretti, Wenbin Zhang, Wenjiong Zhou, et al.
Pain and Therapy
|
June 24, 2024
Efficacy and Safety of Trazodone and Gabapentin Fixed-Dose Combination in Patients Affected by Painful Diabetic Neuropathy: Randomized, Controlled, Dose-Finding Study
Solomon Tesfaye, Ponnusamy Saravanan, Edvard Ehler, et al.
Diabetes Technology & Therapeutics
|
May 15, 2020
DIABEO System Combining a Mobile App Software With and Without Telemonitoring Versus Standard Care: A Randomized Controlled Trial in Diabetes Patients Poorly Controlled with a Basal-Bolus Insulin Regimen
Sylvia Franc, Hélène Hanaire, Pierre-Yves Benhamou, et al.
JMIR Research Protocols
|
April 21, 2018
DIABEO App Software and Telemedicine Versus Usual Follow-Up in the Treatment of Diabetic Patients: Protocol for the TELESAGE Randomized Controlled Trial
Nathalie Jeandidier, Lucy Chaillous, Sylvia Franc, et al.
Journal of Diabetes Science and Technology
|
March 14, 2019
Remote Monitoring of Diabetes: A Cloud-Connected Digital System for Individuals With Diabetes and Their Health Care Providers
Michael Joubert, Pierre-Yves Benhamou, Pauline Schaepelynck, et al.
Journal of Diabetes Science and Technology
|
May 19, 2021
Comparing Patch vs Pen Bolus Insulin Delivery in Type 2 Diabetes Using Continuous Glucose Monitoring Metrics and Profiles
Richard M Bergenstal, Mary L Johnson, Vanita R Aroda, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
March 25, 2026
Ten-Year Trends in Healthcare Use and Costs for People Living with Diabetes in France: Results from the Epicodiab Study Based on National Claims Data
Michael Joubert, Pierre Serusclat, Emilie Casarotto, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
September 3, 2025
Nationwide Trends in Type 1 and Type 2 Diabetes in France (2010-2019): A Population-Based Study Using a Machine Learning Classification Algorithm
Guy Fagherazzi, Pierre Serusclat, Barbara Roux, et al.
Diabetes Care
|
August 17, 2016
Benefits of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide, Versus Insulin Glargine and Lixisenatide Monocomponents in Type 2 Diabetes Inadequately Controlled on Oral Agents: The LixiLan-O Randomized Trial
Julio Rosenstock, Ronnie Aronson, George Grunberger, et al.
JAMA
|
March 24, 2019
Effect of Additional Oral Semaglutide vs Sitagliptin on Glycated Hemoglobin in Adults With Type 2 Diabetes Uncontrolled With Metformin Alone or With Sulfonylurea: The PIONEER 3 Randomized Clinical Trial
Julio Rosenstock, Dale Allison, Andreas L Birkenfeld, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
May 19, 2019
Safety and Effectiveness of Bexagliflozin in Patients With Type 2 Diabetes Mellitus and Stage 3a/3b CKD
Andrew S Allegretti, Wenbin Zhang, Wenjiong Zhou, et al.
Pain and Therapy
|
June 24, 2024
Efficacy and Safety of Trazodone and Gabapentin Fixed-Dose Combination in Patients Affected by Painful Diabetic Neuropathy: Randomized, Controlled, Dose-Finding Study
Solomon Tesfaye, Ponnusamy Saravanan, Edvard Ehler, et al.
Diabetes Technology & Therapeutics
|
May 15, 2020
DIABEO System Combining a Mobile App Software With and Without Telemonitoring Versus Standard Care: A Randomized Controlled Trial in Diabetes Patients Poorly Controlled with a Basal-Bolus Insulin Regimen
Sylvia Franc, Hélène Hanaire, Pierre-Yves Benhamou, et al.
JMIR Research Protocols
|
April 21, 2018
DIABEO App Software and Telemedicine Versus Usual Follow-Up in the Treatment of Diabetic Patients: Protocol for the TELESAGE Randomized Controlled Trial
Nathalie Jeandidier, Lucy Chaillous, Sylvia Franc, et al.
Journal of Diabetes Science and Technology
|
March 14, 2019
Remote Monitoring of Diabetes: A Cloud-Connected Digital System for Individuals With Diabetes and Their Health Care Providers
Michael Joubert, Pierre-Yves Benhamou, Pauline Schaepelynck, et al.
Journal of Diabetes Science and Technology
|
May 19, 2021
Comparing Patch vs Pen Bolus Insulin Delivery in Type 2 Diabetes Using Continuous Glucose Monitoring Metrics and Profiles
Richard M Bergenstal, Mary L Johnson, Vanita R Aroda, et al.
Page
of 2